chr21-46602608-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000397648.1(S100B):c.-193C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0299 in 541,620 control chromosomes in the GnomAD database, including 1,110 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.061 ( 741 hom., cov: 33)
Exomes 𝑓: 0.018 ( 369 hom. )
Consequence
S100B
ENST00000397648.1 5_prime_UTR
ENST00000397648.1 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.319
Publications
5 publications found
Genes affected
S100B (HGNC:10500): (S100 calcium binding protein B) The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 21q22.3. This protein may function in Neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer's disease, Down's syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma, and type I diabetes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.183 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| S100B | NM_006272.3 | c.-1-192C>A | intron_variant | Intron 1 of 2 | ENST00000291700.9 | NP_006263.1 | ||
| S100B | XM_017028424.3 | c.-8-185C>A | intron_variant | Intron 1 of 2 | XP_016883913.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| S100B | ENST00000397648.1 | c.-193C>A | 5_prime_UTR_variant | Exon 1 of 2 | 1 | ENSP00000380769.1 | ||||
| S100B | ENST00000291700.9 | c.-1-192C>A | intron_variant | Intron 1 of 2 | 1 | NM_006272.3 | ENSP00000291700.4 | |||
| S100B | ENST00000367071.4 | c.-1-192C>A | intron_variant | Intron 1 of 3 | 1 | ENSP00000356038.4 |
Frequencies
GnomAD3 genomes AF: 0.0607 AC: 9234AN: 152036Hom.: 735 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
9234
AN:
152036
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0178 AC: 6941AN: 389466Hom.: 369 Cov.: 5 AF XY: 0.0205 AC XY: 4199AN XY: 204372 show subpopulations
GnomAD4 exome
AF:
AC:
6941
AN:
389466
Hom.:
Cov.:
5
AF XY:
AC XY:
4199
AN XY:
204372
show subpopulations
African (AFR)
AF:
AC:
1981
AN:
10812
American (AMR)
AF:
AC:
255
AN:
12278
Ashkenazi Jewish (ASJ)
AF:
AC:
36
AN:
11970
East Asian (EAS)
AF:
AC:
29
AN:
26902
South Asian (SAS)
AF:
AC:
2766
AN:
32162
European-Finnish (FIN)
AF:
AC:
416
AN:
24516
Middle Eastern (MID)
AF:
AC:
52
AN:
1780
European-Non Finnish (NFE)
AF:
AC:
825
AN:
246430
Other (OTH)
AF:
AC:
581
AN:
22616
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
289
578
866
1155
1444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0609 AC: 9259AN: 152154Hom.: 741 Cov.: 33 AF XY: 0.0613 AC XY: 4562AN XY: 74400 show subpopulations
GnomAD4 genome
AF:
AC:
9259
AN:
152154
Hom.:
Cov.:
33
AF XY:
AC XY:
4562
AN XY:
74400
show subpopulations
African (AFR)
AF:
AC:
7722
AN:
41460
American (AMR)
AF:
AC:
407
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
11
AN:
3470
East Asian (EAS)
AF:
AC:
23
AN:
5184
South Asian (SAS)
AF:
AC:
522
AN:
4824
European-Finnish (FIN)
AF:
AC:
215
AN:
10596
Middle Eastern (MID)
AF:
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
AC:
224
AN:
68014
Other (OTH)
AF:
AC:
117
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
388
776
1164
1552
1940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.